PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
84.51
+0.10 (0.12%)
At close: Jun 25, 2026, 4:00 PM EDT
84.50
-0.01 (-0.01%)
Pre-market: Jun 26, 2026, 8:42 AM EDT
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $7.01 billion as of June 26, 2026. Its market cap has increased by 70.94% in one year.
Market Cap
7.01B
Enterprise Value
7.84B
1-Year Change
70.94%
Ranking
Category
Stock Price
$84.51
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $7.01B, an increase of 1,814.27%. That is a compound annual growth rate of 25.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 7.01B | 14.94% |
| Dec 31, 2025 | 6.10B | 75.18% |
| Dec 31, 2024 | 3.48B | 67.39% |
| Dec 29, 2023 | 2.08B | -24.20% |
| Dec 30, 2022 | 2.74B | -2.56% |
| Dec 31, 2021 | 2.82B | -32.38% |
| Dec 31, 2020 | 4.16B | 40.68% |
| Dec 31, 2019 | 2.96B | 70.95% |
| Dec 31, 2018 | 1.73B | 150.23% |
| Dec 29, 2017 | 692.00M | 84.83% |
| Dec 30, 2016 | 374.40M | -66.28% |
| Dec 31, 2015 | 1.11B | -36.17% |
| Dec 31, 2014 | 1.74B | 311.45% |
| Dec 31, 2013 | 422.80M | 15.46% |
| Jun 20, 2013 | 366.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 7.89B |
| Immunovant | 7.84B |
| Vaxcyte | 7.75B |
| Spyre Therapeutics | 7.70B |
| TG Therapeutics | 7.60B |
| Rhythm Pharmaceuticals | 7.42B |
| ABIVAX Société Anonyme | 7.30B |
| Mirum Pharmaceuticals | 7.15B |